Cathie Wood Bets Big On Self-Driving and Gene-Editing Stocks Ahead of 2026

This article first appeared on GuruFocus.

Cathie Wood’s ARK Invest made additional portfolio adjustments, continuing moves seen in prior sessions.

The firm increased holdings in WeRide Inc. (NASDAQ:WRD), a self-driving technology developer. ARK purchased 101,637 shares through its ARK Autonomous Technology & Robotics ETF (ARKQ) for roughly $902,000.This follows earlier purchases on Dec. 22 and Dec. 23, signaling continued confidence in the company’s growth prospects.

ARK also added to positions in CRISPR Therapeutics (NASDAQ:CRSP). The fund bought 10,353 shares through the ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG), valued at around $585,000. Earlier buys in the stock were recorded on Dec. 22 and Dec. 23, highlighting sustained interest in the gene-editing sector.

On the selling side, ARK trimmed its stake in Ibotta Inc. (NYSE:IBTA), disposing of 101 shares through the ARK Next Generation Internet ETF (ARKW) for about $2,200. This follows small reductions in recent sessions, reflecting a measured approach to portfolio rebalancing.